Evidence map›Paper›PMID 37702088›Full record

ArticleInfection control and hospital epidemiology2024

Assessing past versus present severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection: A survey of criteria for discontinuing precautions in asymptomatic patients testing positive on admission.

Shruti K Gohil, Annabelle De St Maurice, Deborah S Yokoe, Stuart H Cohen, Francesca J Torriani, Jonathan D Grein, Philip A Robinson, Shannon Mabalot, Jessica Park, Paula Pedrani and 2 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection control and hospital epidemiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 84% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 0 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 1 country.

Shruti K GohilEpidemiology & Infection Prevention Program, University of California, Irvine Health (UC Irvine Health), Irvine, California.ORCID 0000-0003-1932-7540
Annabelle De St MauriceDivision of Pediatric Infectious Diseases, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California.
Deborah S YokoeUniversity of California, San Francisco, Division of Infectious Diseases, San Francisco, California.
Stuart H CohenUniversity of California, Davis, Division of Infectious Diseases, Davis, California.
Francesca J TorrianiUniversity of California, San Diego, Division of Infectious Diseases, San Diego, California.
Jonathan D GreinCedars Sinai Medical Center, Division of Infectious Diseases, Los Angeles, California.
Philip A RobinsonHoag Memorial Hospital Presbyterian, Department of Infection Prevention, Newport Beach and Irvine, California.
Shannon MabalotInfection Prevention, Sharp Metropolitan Medical Campus, San Diego, California.
Jessica ParkDivision of Infectious Diseases, University of California, Irvine School of Medicine, Irvine, California.
Paula PedraniDivision of Infectious Diseases, University of California, Irvine School of Medicine, Irvine, California.
Richard PlattDepartment of Population Medicine, Harvard Pilgrim Healthcare Institute, Harvard Medical School, Boston, Massachusetts.
Susan S HuangEpidemiology & Infection Prevention Program, University of California, Irvine Health (UC Irvine Health), Irvine, California.ORCID 0000-0001-6748-3447
University of California, Irvine · USCedars-Sinai Medical Center · USHarvard University · USHoag Memorial Hospital Presbyterian · USUniversity of California, Davis · USUniversity of California, Los Angeles · USUniversity of California San Diego · USUniversity of California, San Francisco · US

Funding

NCEZID CDC HHS U54 CK000484
6 · The paper itself

Abstract

Infection prevention program leaders report frequent use of criteria to distinguish recently recovered coronavirus disease 2019 (COVID-19) cases from actively infectious cases when incidentally positive asymptomatic patients were identified on routine severe acute respiratory coronavirus virus 2 (SARS-CoV-2) polymerase chain reaction (PCR) testing. Guidance on appropriate interpretation of high-sensitivity molecular tests can prevent harm from unnecessary precautions that delay admission and impede medical care.

Indexed as

COVID-19COVID-19 TestingHumansSARS-CoV-2

Identifiers

PMID37702088
PMCPMC10877527
OpenAlexW4386704823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.